Jefferies Maintains a Buy on Inspire Medical Systems (INSP) With a $160 PT

Inspire Medical Systems, Inc. (NYSE:INSP) is one of the best medical device stocks to buy according to analystsJefferies analyst Michael Sarcone maintained a Buy rating on Inspire Medical Systems, Inc. (NYSE:INSP) on August 5, setting a price target of $160.00.

A medical professional performing a minimally invasive procedure while using the company’s technology.

The rating update followed Inspire Medical Systems, Inc.’s (NYSE:INSP) release of fiscal Q2 2025 results on August 4. The company generated $217.1 million in revenue in fiscal Q2 2025, reflecting an 11% growth over the same quarter in 2024.

It achieved a gross margin of 84.0%, while net loss for the quarter was $3.6 million. Inspire Medical Systems, Inc. (NYSE:INSP) also reported adjusted diluted earnings per share of $0.45.

Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company that develops and commercializes innovative, minimally invasive solutions for obstructive sleep apnea.

The company offers Inspire therapy, which includes implantable components with a pressure-sensing lead, a stimulation lead, and a neurostimulator, operable through a remote control.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.